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The vaccinia virus (V V) 39-kDa protein, the product of the A4L gene, is a highly antigenic protein of the viral core.
Pulse-chase and immunoprecipitation experiments have shown that the 39-kDa protein interacts with p4a (encoded by the
A10L gene), the precursor of the most abundant virion protein. This interaction is maintained with the processed 4a form that
arises during virion maturation. The controlled disruption of mature viral particles showed that the 39-kDa and 4a proteins
are tightly bound within the virion. Immunoelectron microscopy showed that both proteins first localize within the cytoplasm
and later accumulate inside the viral factories, reaching these locations via a mechanism apparently unrelated to cellular
membranes. Double labeling experiments showed a colocalization of both proteins in all virus-induced structures. © 1999
Academic Press
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Vaccinia virus (V V) is a large double-stranded DNA
irus and the best studied member of the Poxviridae
amily, a group of animal viruses whose life cycle takes
lace entirely in the cytoplasm of the infected cells (re-
iewed by Moss, 1990). At late times during this life
ycle, a series of events lead to the formation of the
ntracellular mature virion (IMV), through a process
hose complexity could be compared with the biogen-
sis of cellular organelles (Wang and Shuman, 1995).
he first viral structures that can be visualized in the
ytoplasm of infected cells are crescent-shaped mem-
ranes, whose origin remains controversial. In the orig-
nal model proposed by Dales et al. (1961, 1968) viral
embranes would be synthesized de novo by an un-
nown mechanism. More recently, Sodeik et al. (1993)
roposed that the IMV membrane is of cellular origin and
erived from the endoplasmic reticulum–Golgi interme-
iate compartment (ERGIC), one of the components of
he constitutive secretory pathway of the cell. In accor-
ance with this model, several viral proteins have been
hown to be associated with membranes of this tubu-
ovesicular compartment (Krijnse-Locker et al., 1996; Ro-
rı´guez et al., 1997; Salmons et al., 1997). These virus-
1 Present address: Department of Medicine, University of Massachu-
etts Medical Center, Worcester, MA 01655.
2 Present address: Department of Medical Biochemistry, University of
ulu, Finland.
3 To whom reprint requests should be addressed. Fax: 34-1-585-
n506. E-mail: mesteban@cnb.uam.es.
375odified membranes, which would then consist of two
ipid bilayers, would be later recruited to the periphery of
he viral factories to form the characteristic crescent-
haped membranes (Krijnse-Locker et al., 1996; Rodrı´-
uez et al., 1997). However, this model has lately been
isputed by Hollinshead et al. (1999), who claimed that
here is no continuity between cellular and viral mem-
ranes and that the latter are made of only one lipid
ilayer and invoke again the de novo synthesis for the
rigin of IMV membrane. Regardless of the origin of the
iral membrane, the next step in V V morphogenesis is
he formation of immature virus (IV), a process during
hich electron-dense material from the viral factory be-
omes engulfed by the viral membrane (Ichihashi et al.,
971; Silver and Dales, 1982). The IV undergoes a major
tructural transformation to produce the IMV, and this
ppears to involve the proteolytic processing of certain
olypeptide precursors (Lee and Hruby, 1994; Moss and
osenblum, 1973; Silver and Dales, 1982; Vanslyke et al.,
991) and the intervention of some particular proteins
Hu et al., 1996; Kane and Shuman, 1993; Klemperer et
l., 1997; Ravanello and Hruby, 1994; Zhang and Moss,
991), one of which has been recently reported to be
equired for DNA packaging (Cassetti et al., 1998). A
raction of the IMVs is later wrapped by a membrane
isternae derived from the trans-Golgi network, to be
ater released from the cell via fusion with the plasma
embrane (Dales and Pogo, 1981; Payne and Kristenson,
979; Schmelz et al., 1994), with the participation of V V
roteins that play specific roles in these final morphoge-
etic steps (Blasco and Moss, 1991; Duncan and Smith,
0042-6822/99 $30.00
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376 RISCO ET AL.992; Engelstad and Smith, 1993; Parkinson and Smith,
994; Rodrı´guez and Smith, 1990). Recent studies have
tarted to provide information about the complex molec-
lar events involved in the early morphogenetic process
or which the formation of complexes of V V proteins
ust be crucial (Rodrı´guez et al., 1993, 1995, 1996, 1997).
n this respect, a protein complex constituted by V V
1-kDa (A17L), 15-kDa (A14L), and 14-kDa (A27L) enve-
ope proteins has been recently described (Rodrı´guez et
l., 1997). The 21-kDa and the 15-kDa proteins play es-
ential roles in the biogenesis of the first viral mem-
ranes, the viral crescents (Rodrı´guez et al., 1995, 1996,
998; Wolffe et al., 1996), whereas the 14-kDa protein is
equired for the envelopment of IMVs with Golgi-derived
embranes (Rodrı´guez and Smith, 1990). The 65-kDa
rotein, the product of the D13L gene and the target of
he drug rifampin (Miner and Hruby, 1989; Tartaglia et al.,
986; Zhang and Moss, 1992), probably acts as a scaf-
olding protein, providing the curvature typical of the
rescents (Sodeik et al., 1994). In addition, temperature-
ensitive (ts) mutants with lesions in the F10 protein
inase showed that F10 and/or its associated kinase
ctivity plays a crucial role in the initiation of virion
ssembly (Traktman et al., 1995; Wang and Shuman,
995).
Poorly characterized aspects of the sequence of V V
ssembly are how the viral core proteins are transported
o the viral factory and how the dense content of the
actory becomes associated with the membranes during
he formation of the viral crescents and immature virions.
t has been suggested that viral core proteins could bind
o an unidentified viral transmembrane protein or pro-
eins, resulting in the formation of the crescents and,
ubsequently, the immature virions (Sodeik et al., 1993).
oimmunoprecipitation experiments have suggested
hat the 21-kDa envelope protein could interact with the
9-kDa core protein (Cudmore et al., 1996). The 39-kDa
rotein, which is the product of the A4L gene, is an
mmunodominant protein first described by Maa and
steban (1987), who demonstrated that this acidic
olypeptide is a product of the late class of genes and is
resent in the V V core. The 39-kDa protein elicits strong
umoral immune responses in humans and animals,
eing the strongest antigenic domain contained within
he C-terminal 103 amino acids (Demkowicz et al., 1992).
his protein localizes in the viroplasm of the viral facto-
ies and rifampin bodies (Cudmore et al., 1996) and in the
ore of the IMV, where it has been proposed to act as a
atrix protein, connecting the surface of the core with
he innermost membrane of the IMV particle (Ross et al.,
996). Moreover, it has been recently shown that this
rotein is essential for V V growth, being required for the
rogression of IV to IMV particles (Williams et al., 1999).
quivalent proteins to V V 39 kDa, showing variable de-
rees of homology, are found in other members of the
oxvirus family: fowlpox (Boulanger et al., 1998), Mollus- rum contagiosum (Senkevich et al., 1996), and variola
Bangladesh 1975) (Massung et al., 1994) viruses. The
owlpox 39-kDa homolog is also an immunodominant
rotein and shows the same localization in viral factories
nd mature virions as the V V 39-kDa protein. In the
resent study, we identified and characterized the forma-
ion of a stable complex between the V V 39-kDa protein
nd another immunodominant core protein, p4a/4a,
hich is the product of the A10L gene and represents the
ost abundant protein of the virion (Sarov and Joklik,
972). This major core antigen, which could represent
he common nucleoprotein agent found in most mem-
ers of the poxvirus family (Woodroofe and Fenner, 1962),
s an important determinant in the immune response
ounted against V V. We have found that the association
9-kDa–p4a/4a is established early in morphogenesis
nd maintained after their incorporation into virions and
he proteolytic processing of p4a precursor, which points
o a key role for that interaction in virion architecture. In
ddition, the localization of both proteins within the viral
actory and some other virus-induced structures raises
ome questions about the internal organization and ori-
in of these centers of assembly.
RESULTS
he V V 39-kDa protein interacts with the precursor
nd the processed form of the V V 4a major core
rotein
In previous studies, we have characterized through
mmunoprecipitation analysis the interaction between
everal V V membrane proteins that may be relevant for
he formation of the mature virion envelope (Rodrı´guez et
l., 1993, 1995, 1996, 1997). Protein–protein interactions
re also likely to occur between the proteins involved in
he maturation of the viral core. With the aim of identify-
ng such interactions, we performed immunoprecipita-
ion experiments using extracts from V V-infected cells
nd antibodies against the 39-kDa core protein
Demkowicz et al., 1992; Maa and Esteban, 1987). For
his, BSC40 cells infected with Western reserve (WR) V V
10 PFU/cell) were metabolically labeled with [35S]methi-
nine from 6 to 24 h postinfection (p.i.). Cells were lysed
y incubation at 37°C during 30 min in lysis buffer. Cell
xtracts were cleared by centrifugation and incubated
ith Sepharose beads coated with polyclonal anti-39-
Da antibodies, and the immunoprecipitated proteins
ere analyzed by SDS–PAGE. As shown in Fig. 1A, lane
, in addition to the 39-kDa protein, the anti-39-kDa an-
ibody coprecipitated two proteins with apparent molec-
lar masses of ;100 and ;60 kDa from extracts of
nfected cells. The upper of these two bands (denoted by
ne asterisk) was the predominant product coprecipi-
ated with the 39-kDa protein from extracts of cells in-
ected in the presence of rifampin (lane 2), a drug that
eversibly blocks V V morphogenesis at a step previous
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37739-kDa–p4a/4a PROTEIN COMPLEX DURING V V ASSEMBLYo the cleavage of the core precursors p4a and p4b
Moss et al., 1971). None of these two proteins were
bserved when immunoprecipitation was performed
ith antibodies against the V V L1R protein (lanes 3 and
), which excludes the possibility that p4a and 4a copre-
ipitation could simply be due to aggregation or nonspe-
ific binding of these proteins to the Sepharose beads
uring the incubations. These results suggested that the
9-kDa protein associates with a polypeptide that is
roteolytically cleaved during virion assembly. After this
ypothesis and in consideration of the molecular sizes of
he two coprecipitating proteins, the most likely candi-
ates were the p4a precursor and its 4a cleaved product,
hose predicted molecular weights are 102 and 62 kDa,
espectively (Vanslyke et al., 1991). To investigate this
ossibility, similar cell lysates were immunoprecipitated
ith antibodies raised against the 4a product or with
nti-39-kDa antibodies, and the immunoprecipitated pro-
eins were run in parallel in SDS–PAGE. As shown in Fig.
B, the anti-p4a/4a antibodies clearly immunoprecipi-
ated both the p4a precursor and the 4a protein (lane 4),
nd these proteins comigrated with the two products
oprecipitated by anti-39-kDa antibodies (lane 1). To
uarantee that the coprecipitation of p4a and 4a was not
ue to nonspecific cross-reactivity of anti-39K antibodies
ith these two proteins in this experiment, we performed
similar immunoprecipitation with lysates from cells
nfected with a mutant virus, vA5Li, that inducibly ex-
FIG. 1. V V 39-kDa protein interacts with the major p4a and 4a protein
V (10 PFU/cell) in the absence (lanes 1 and 3) or presence (lanes 2 a
rom 6 to 24 h p.i. Cells were harvested and treated with lysis buffer fo
he 39-kDa (lanes 1 and 2) or L1R (lanes 3 and 4), fractionated by SDS–
ith the 39-kDa protein are indicated on the left side by one or two as
pecific coprecipitation of p4a and 4a with the 39-kDa protein. BSC40
A5Li in the presence (lanes 2 and 5) or absence (lanes 3 and 6) o
mmunoprecipitated with antibodies specific for the 39-kDa (lanes 1–3)
y SDS treatment. Cells infected (10 PFU/cell) with WR were treated w
t 37°C, proteins were immunoprecipitated with anti-39-kDa antibodies
f B and C.resses the 39-kDa protein (Williams et al., 1999). Immu- koprecipitation of p4a and 4a with anti-39K antibodies
as observed when cells were infected with the mutant
n the presence of the inducer (lane 2), conditions under
hich 39-kDa protein is produced but not when expres-
ion of 39-kDa was repressed [2isopropyl-b-D-thioga-
actoside (IPTG)] (lane 3), although these two products
ould be clearly immunoprecipitated by the specific anti-
4a/4a antiserum (lane 6) to the same extent as from
R-infected cells (lane 4) or from cells infected with the
utant in the presence of the inducer (lane 5). These
esults clearly demonstrated that immunoprecipitation of
4a and 4a products with anti-39-kDa antibodies is due
o their specific interaction with the 39-kDa protein.
To further characterize the nature of this 39-kDa–
4a/4a complex cell lysates were treated with the an-
onic detergent SDS before immunoprecipitation. As
hown in Fig. 1C, after treatment of the cells with SDS,
he anti-39-kDa antibodies immunoprecipitated only the
9-kDa protein (lane 2), indicating that the 39-kDa–
4a/4a interaction is disrupted by this treatment.
The identity of the coprecipitated proteins as V V p4a
nd 4a polypeptides was also confirmed by reacting in
estern blotting the immunoprecipitated products with
ntibodies against the 4a protein (not shown); however,
e could not observe coprecipitation of the 39-kDa pro-
ein with anti-p4a/4a antibodies Fig. 1B, (lanes 5 and 6).
Taken together, these results suggest that the 39-kDa
rotein interacts with the p4a and 4a proteins. The 39-
munoprecipitation with anti-39K antibodies. BSC40 cells infected with
f rifampin (100 mg/ml) were metabolically labeled with [35S]methionine
in at 37°C. Proteins were immunoprecipitated with antibodies against
and detected by autoradiography. Two proteins coimmunoprecipitated
. The positions of the 39-kDa and L1R proteins are also indicated. (B)
ere infected (10 PFU/cell) with WR (lanes 1 and 4) or with the mutant
IPTG and metabolically labeled as described in A. Proteins were
4a (lanes 4–6) proteins. (C) The 39 kDa–p4a/4a interaction is disrupted
s buffer containing (lane 2) or lacking (lane 1) 0.2% SDS. After 30 min
ositions of p4a, 4a, and 39-kDa proteins are indicated on the right sides. (A) Im
nd 4) o
r 30 m
PAGE,
terisks
cells w
f 50 mM
or p4a/
ith lysi
. The pDa and 4a proteins are tightly bound within the virion,
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378 RISCO ET AL.nd this interaction is broken by treatment with anionic
etergents.
ime course of the p4a proteolytic processing and its
nteraction with the 39-kDa protein
To study in more detail the kinetics of the 39-kDa–
4a/4a interaction, we performed a pulse-chase analy-
is. Thus, cells were pulse-labeled for 10 min with
35S]methionine at 6 h p.i. Immediately thereafter, a 100-
old excess of unlabeled methionine was added to the
ells, and one culture was placed on ice and washed
ith PBS (time 0). The other cultures were further incu-
ated at 37°C and harvested at 0.25, 0.5, 1, and 18 h after
he chase. In Fig. 2A, which shows the profile of [35S]la-
eled proteins at different times after the chase, the
isappearance of the p4a and p4b major core precursors
ith time and the corresponding increase in the amount
f both 4a and 4b mature products can be observed. The
inetics of p4a proteolytic processing can be more
learly observed in Fig. 2B after immunoprecipitation of
he cell extracts with the anti-p4a/4a antiserum. A clear
ecrease in the amount of p4a precursor was observed
ith the time of chase that was concomitant with the
ppearance of the 4a mature product (lanes 4 and 5). A
imilar picture was obtained when immunoprecipitation
as carried out with anti-39-kDa antibodies, although in
his case the 39-kDa protein was present at all times
fter chase (Fig. 2C). These results indicate that soon
fter its synthesis, the 39-kDa protein interacts with the
4a core precursor, and this interaction is maintained
ith the processed 4a protein that arises after virion
FIG. 2. Kinetics of the 39-kDa–p4a/4a protein complex formation in
nfected with WR V V (10 PFU/cell), which were pulse-labeled with [35S
xcess of unlabeled methionine. Cells were harvested immediately afte
espectively) and resuspended in lysis buffer, and an aliquot of each s
he gel was dried, and protein bands were visualized after autoradiogr
mmunoprecipitation with antibodies against p4a/4a proteins. (C) Kineti
ith antibodies against the 39-kDa protein. Immunoprecipitated prote
ositions of precursors p4a and p4b and the cleaved products 4a and 4
s also indicated in C.aturation. focalization of the 39-kDa and 4a proteins within the
irion
Both 39-kDa and 4a have been defined as core pro-
eins. Recently, it has been proposed that the 39-kDa
rotein is a membrane-associated protein that localizes
n the outside of the viral core (Cudmore et al., 1996). To
stablish the relative position of 39-kDa and 4a proteins
ithin the viral particle, we treated purified virions with
ifferent detergents and a reducing agent to selectively
olubilize their proteins and fractionate their compo-
ents. The 4a protein was only partially solubilized after
he treatment of virions with SDS and DOC (Fig. 3A, lane
), and ;50% of the protein remained in the insoluble
raction after this treatment (Fig. 3A, lane 1). In contrast,
he majority of the 39-kDa protein was solubilized by
reatment with SDS and DOC (Fig. 3B, lane 2), although
considerable amount of it was already released by
reatment with DTT in combination with Nonidet P-40
NP-40) (Fig. 3B, lane 3), and a small amount was solu-
ilized by only NP-40 (Fig. 3B, lane 4). However, as
iscussed earlier, a portion of the protein remained in-
oluble after the different extraction treatments (Fig. 3B,
ane 1). A comparison with the distribution obtained
hen localizing a membrane protein, the 15-kDa protein,
s shown in Fig. 3C. This envelope protein was almost
otally extracted by the sequential treatment with NP-40
nd NP-40 plus DTT (Fig. 3C, lanes 4 and 3, respectively).
This result indicated that the 4a protein is more con-
ined within the core structure, whereas, in agreement
ith previous reports (Cudmore et al., 1996; Ross et al.,
996), the 39-kDa protein might be localized on the sur-
V-infected cells. (A) Profile of radiolabeled protein from BSC40 cells
nine at 6 h p.i. After 10-min pulse, cells were chased with a 100-fold
ulse (lane 1) or after 0.25-, 0.5-, 1-, and 18-h chase periods (lanes 2–5,
was mixed with 23 sample buffer and analyzed by SDS–PAGE (10%).
) Kinetics of p4a proteolytic processing analyzed by pulse-chase and
e 39-kDa–p4a/4a complex formation analyzed by immunoprecipitation
re separated by SDS–PAGE and visualized by autoradiography. The
dicated on the left side of A. Migration of p4a, 4a, and 39-kDa proteinsWR V
]methio
r the p
ample
aphy. (B
cs of th
ins we
b are inace of the viral core.
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37939-kDa–p4a/4a PROTEIN COMPLEX DURING V V ASSEMBLYhe 39-kDa and p4a V V core proteins colocalize
nside viral factories
Ultrathin sections of infected cells embedded in Lowi-
ryl K4M were used in a first step of this study to follow
he intracellular distribution of the viral proteins during
V assembly. The cells were subjected to a mild fixation
nd embedded at a low temperature to facilitate the
reservation of the epitopes and to obtain strong immu-
olabeling signals.
The previously characterized conditional mutant
VindA17L (Rodrı´guez et al., 1995, 1996, 1997), which
nducibly expresses the 21- to 23-kDa envelope protein,
as shown to provide a synchronized system to follow
he incorporation of viral proteins during morphogenesis.
n cells infected with V VindA17L under nonpermissive
onditions, virion morphogenesis is arrested, and elec-
ron-dense masses, similar to viral factories, are the only
iral structures observed at late times postinfection. After
nduction of the A17L gene expression, characteristic
iral factories and the different viral forms can be ob-
erved in the cytoplasm of infected cells. Small viral
actories are visible in perinuclear areas of low electron
ensity shortly after addition of the inducer (2 h). These
actories increase in number and size at longer postin-
FIG. 3. Localization of 39-kDa and 4a proteins within the virion.
urified IMV virions were disrupted by treatment with the nonionic
etergent NP-40 (1%) in Tris buffer (50 mM Tris–HCl, pH 8.5, containing
0 mM MgCl2). This and subsequent treatments were performed at
7°C for 30 min. The soluble envelopes (E1) were removed by centrif-
gation, and the insoluble fraction was resuspended in Tris buffer
ontaining 1% NP-40 plus 50 mM DTT. The soluble proteins (E2) were
ollected, and the pellet was treated with the same buffer containing
% NP-40, 0.5% DOC, and 0.1% SDS. After centrifugation, soluble pro-
eins (E3) were separated from cores (C). Extracts from V V-infected
ells (CE), unfractionated virions (V), and the collected fractions were
esolved by SDS–PAGE under reducing conditions and analyzed by
estern blotting using antibodies against the p4a/4a (A), the 39-kDa
B), or the 15-kDa (C) proteins.uction times (4–18 h). vImmunogold detection indicated that from the begin-
ing of assembly, the 39-kDa and p4a/4a proteins accu-
ulate in the same intracellular localizations (Fig. 4). The
ignal obtained with both antisera at different postinduc-
ion times shows that these proteins are incorporated
nto the viral factories, probably after having been syn-
hesized in free polysomes of the infected cell, as sug-
ested by the scattered labeling observed in the cyto-
lasm at short postinduction times (Fig. 4A). At 2 h after
he addition of IPTG to the cultures, small electron-dense
ytoplasmic masses, as well as small viral factories, are
etectable, and according to the strong labeling signals
bserved, these structures contain both 39-kDa and
4a/4a proteins (Figs. 4A and 4B). At 18 h postinduction,
trong signals associated to both proteins are present
nside large factories (Figs. 4C and 4D).
The distribution of the labeling associated to 39-kDa
nd p4a proteins inside the viral factories does not seem
o correspond to a random pattern, because the organi-
ation in domains, frequently with linear arrays of gold
articles, is very clear (arrows in Figs. 4B–4D).
Double-labeling experiments show that both p4a/4a
nd 39-kDa proteins colocalize inside small and large
actories (Figs. 4E and 4F). The small cytoplasmic elec-
ron-dense spots that form at short postinduction times
lready contain labeling associated to both proteins, as
ell as rifampin bodies and the large dense masses
ormed when infecting with the V VindA17L virus in the
bsence of the inducer (not shown).
ncorporation of 39-kDa and p4a/4a proteins into viral
actories and viral particles does not seem to require
he participation of membranes
Immunolocalization of the core proteins was repeated
n ultrathin sections of cells embedded in an Epon-type
esin (Fig. 5). In these sections, the immunolabeling
ignal is reduced, but as an important advantage, there
s a very good definition of the membranous systems,
oorly defined in conventional Lowicryl sections. The
9-kDa protein did not significantly associate to the tu-
ulovesicular membranes recruited on the periphery of
he factories when infection with the V VindA17L occurs
nder permissive conditions (Fig. 5A). These membra-
ous elements are known to be related to the ERGIC
Rodrı´guez et al., 1997; Sodeik et al., 1993). A similar
esult was obtained when labeling was done with the
nti-p4a/4a antiserum (not shown).
The electron-dense masses that organize in HeLa
ells infected with the recombinant virus V VindA17L un-
er nonpermissive conditions accumulate both 39-kDa
nd p4a proteins (Figs. 5B and 5C). These results sug-
est that both in the presence and absence of viral
ssembly, the 39-kDa and p4a/4a core proteins are effi-
iently incorporated into virus-induced structures (the
iral factories or their precursors) via a mechanism ap-
t
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380 RISCO ET AL.FIG. 4. Colocalization of p4a/4a (62k) and p39-kDa (39 k) in HeLa cells infected with the recombinant virus V VindA17L at different postinduction
imes. Lowicryl K4M sections were used in all experiments. (A–D) Single labeling experiments with 10-nm gold particles. Two hours after the addition
f the inducer (IPTG) to the cell cultures, labeling associated to 62-kDa (A) and 39-kDa (B) V V proteins is detected in the cytoplasm (arrowhead in
) as well as inside small electron-dense masses (arrow in B) and viral factories (F). (C and D) At 18 h postinduction, large viral factories (F) exhibit
strong internal labeling associated to both 62-kDa (C) and 39-kDa (D) proteins. Gold particles frequently organize forming linear arrays (arrows).
E and F) Double labeling experiments, where larger gold particles (10 nm) are associated to p4a/4a protein, and small gold particles (5 nm) are
etecting 39-kDa protein molecules. Both proteins specifically colocalize inside small viral factories formed at 4 h postinduction (E) and large viral
actories from cultures at 18 h postinduction (F). N, cell nucleus; c, viral crescent; RER, rough endoplasmic reticulum. Bars represent 250 nm in A–D
nd 200 nm in E and F.
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38139-kDa–p4a/4a PROTEIN COMPLEX DURING V V ASSEMBLYFIG. 5. 39-kDa and 62-kDa (p4a/4a) V V proteins do not associate in situ to cellular or viral membranes. EML-812 sections of infected HeLa cells
t 24 h p.i. (A–D and F) or suspensions of purified V V IMVs (E and G) were used. (A) In HeLa cells infected with the recombinant virus V VindA17L
n the presence of IPTG, the immunogold signal associated to 39-kDa protein localizes inside the viral factories (F). The tubular membranous elements
T) recruited on the periphery of the factories or the viral crescents (c) are devoid of labeling. In the absence of viral assembly (in HeLa cells infected
ith the recombinant virus V VindA17L in the absence of IPTG), both 39-kDa (B) and 62-kDa (C) V V proteins accumulate inside the perinuclear
lectron-dense masses (asterisks). The numerous tubular (T) and vesicular (V) membranous elements that cover the periphery of the masses are
evoid of labeling. Arrows in B and C point to linear arrays of gold particles. Filamentous elements are clearly distinguished inside the mass shown
n C. (D) In assembled IMV particles, 62-kDa protein is localized associated to the internal viral core (c), and no signal was obtained on the surface
f virions (E). (F and G) Equivalent situation for a V V envelope protein (15-kDa) that localizes on the envelope of sectioned IMVs (F) and on the surface
f purified virions (G). The 10-nm gold particles were used in all immunolabeling assays. Bars, 250 nm.
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382 RISCO ET AL.arently independent of cellular membranes, clearly dif-
erent from the pathway used by V V membrane proteins
uch as 21- to 23-kDa or 15-kDa proteins, that reach the
iral structures in ERGIC-related cellular membranes
Rodrı´guez et al., 1997).
When viral assembly progresses, the 39-kDa and
4a/4a core proteins incorporate inside viral particles.
he labeling pattern obtained clearly differs from the
ignal obtained when localizing a typical V V membrane
rotein such as the 15-kDa protein (Rodrı´guez et al.,
997) (Figs. 5D–5G). No exposure of 4a (Fig. 5E) or
9-kDa (not shown) epitopes was detected on the sur-
ace of the IMV particles, according to immunogold la-
eling of purified IMVs, whereas a moderate exposure of
he peptides detected by the anti-15-kDa antibodies was
bserved (Fig. 5G).
DISCUSSION
The morphogenesis of V V has been the subject of a
umber of reports that revealed the great complexity of
he assembly process and its clear interest from the cell
iology point of view. Recent studies on the identification
f new V V structural proteins and their localization in the
nfected cell are providing molecular data on this com-
lex process, in which several cellular compartments are
nvolved. Our studies had first focused on the interaction
etween several V V membrane proteins and their poten-
ial relevance in the formation of the mature virion enve-
ope. In these studies, a protein complex constituted by
V 21-, 15-, and 14-kDa envelope proteins was charac-
erized. Two of these proteins, the 21- and 15-kDa pro-
eins, were assigned to the V V membrane biogenesis
Rodrı´guez and Smith, 1990; Rodrı´guez et al., 1995, 1996,
997, 1998). The formation of complexes of viral proteins
re also likely to play an important role in the maturation
f the viral core. In the present report, we show through
mmunoprecipitation studies that two V V core proteins,
he 39-kDa protein (Maa and Esteban, 1987) and the
4a/4a, the most abundant protein of the virion (Sarov
nd Joklik, 1972), form a stable complex soon after their
ynthesis. The 39-kDa and 4a proteins remain associ-
ted within the virion after the proteolytic processing of
he p4a precursor that accompanies IV maturation. By
sing antibodies against the 39-kDa protein, we were
ble to coprecipitate the p4a precursor from rifampin-
reated infected cultures and both p4a and 4a proteins
rom cells infected under conditions where virion assem-
ly is allowed to proceed normally. The identity of the
oprecipitated products as the V V p4a and 4a proteins
as unequivocally established by their reactivity with an
nti-p4a/4a serum on Western blotting. Neither of these
wo proteins was observed in parallel immunoprecipita-
ions with antibodies against a different V V polypeptide,
he L1R envelope protein, indicating the specificity of the
9-kDa–p4a/4a coprecipitation. However, it was still pos- Tible that the immunoprecipitation of p4a and 4a proteins
as due to cross-reactivity of the anti-39-kDa antibodies
ith these two proteins. We have ruled out this possibil-
ty by using a mutant virus that inducibly expresses the
9-kDa protein and showing that neither of these two
roducts was immunoprecipitated by the anti-39-kDa
ntibodies when expression of the 39-kDa protein was
epressed, conditions under which they could be immu-
oprecipitated by an anti-p4a/4a antibody.
We studied the kinetics of this interaction by pulse-
hase and immunoprecipitation and observed that soon
fter its synthesis, the 39-kDa protein interacts with the
recursor p4a. Coprecipitation of 4a protein was clearly
bserved 1 h after the chase, which coincides with the
ime at which this product was first detected with the
pecific anti p4a/4a antibody. Interestingly, at the latest
ime point, the amount of the 4a product coprecipitated
as higher than the amount of the 39-kDa protein itself.
his might indicate that within the virion, the interaction
s not at 1:1 molar ratio. In support of this hypothesis is
he fact that the 62-kDa protein is the most abundant
rotein of the virion, representing 14% of the particle’s dry
eight (Sarov and Joklik, 1972). In addition, a differential
epresentation of the two proteins within the complex
ould provide an explanation for the inability to detect
9-kDa protein coprecipitating when we use antibodies
gainst the 4a protein. However, a different situation is
bserved in the interaction between 39-kDa protein and
he p4a precursor, where only a fraction of p4a synthe-
ized can be coprecipitated by the 39-kDa antibodies,
nd this would suggest that the stoichiometry of the
nteraction varies during the assembly process.
Another question that arises from the immunoprecipi-
ation experiments is why antibodies to 39-kDa protein
re more effective in immunoprecipitating the 4a protein
han the anti-p4a/4a antibodies. In this regard, the grad-
al disruption of virions showed that 4a protein occupied
more internal location, whereas 39-kDa protein locates
ore externally and that would be compatible with the
atter being a matrix-like protein, acting as a link between
he core and the surrounding membranes, as previously
roposed (Cudmore et al., 1996; Ross et al., 1996). Then,
fter treatment of cell extracts with NP-40, DOC, and DTT,
he envelope proteins could be removed from virions,
nd the 39-kDa protein would be exposed and accessi-
le to be immunoprecipitated by the anti-39-kDa-specific
ntibodies and, in turn, would bring down the 4a protein.
n the other hand, 4a protein would be buried within the
ore structure and hidden from its own antibodies.
It has been suggested that the 39-kDa protein may
nteract with the 21-kDa (A17L gene product) envelope
rotein (Cudmore et al., 1996). However, in our immuno-
recipitation experiments, we have not observed copre-
ipitation of the 21-kDa protein with the 39-kDa protein.
his apparent discrepancy may be due to the different
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38339-kDa–p4a/4a PROTEIN COMPLEX DURING V V ASSEMBLYntibodies and immunoprecipitation conditions used in
oth studies.
Before being incorporated into the IMV structure, 39-
Da and p4a proteins together with the remainder of V V
ore proteins are part of the viroplasm, a poorly defined
tructure that includes many of the structural proteins of
he IMV (Vanslyke and Hruby, 1994; Wang and Shuman,
995). This dense material fills the immature virions and,
efore them, the viral factories. In this regard, we have
bserved that the viral factories, rifampin bodies, and
lectron-dense masses exhibit internal structures that
uggest a network-like organization (see Fig. 5). Modi-
ied membranes, proteinaceous filaments, or even DNA
ibers covered by proteins could participate in this orga-
ization. The viral factories, and the other assemblies
hat relate to them (rifampin bodies and electron-dense
asses), are occasionally found in the extracellular en-
ironment, keeping their size and shape and frequently
lso their viral crescents (Risco et al., unpublished re-
ults). Regardless of the origin of these extracellular
tructures (probably released by cell lysis), they must be
ather compact and organized structures. Another unde-
ined process is how 39-kDa and p4a proteins reach the
iral factories after being apparently synthesized by free
ibosomes. This transport does not seem to be related to
RGIC membranous elements, as in the case of V V 21 or
5-kDa envelope proteins (Krijnse-Locker et al., 1996;
odrı´guez et al., 1997), which suggests that either the
ore proteins are transported to the factories in associ-
tion with some as-yet-unidentified cellular elements or
he factories could organize around cytoplasmic accu-
ulations of 39-kDa and p4a protein-containing viral
lements. No ribosomes were clearly seen inside the
actories, as previously indicated by Cudmore et al.
1996), although their presence cannot be discarded until
more detailed analysis of the ultrastructure and com-
osition of the viral factory is completed. According to
ouble-labeling experiments, both proteins colocalize in
ll areas where an accumulation of gold particles is
bserved. Although weak, scattered labeling in cytoplas-
ic areas is constituted by separated signals, in all
pots with significant accumulations of gold particles,
oth 5- and 10-nm signals coexist.
Because the association between the core proteins
9-kDa and p4a/4a takes place early in morphogenesis
nd occurs even before the proteolytic processing of the
4a precursor, it could be one of the protein complexes
undamental for the construction of the mature infectious
irus. Finally, a detailed characterization of the internal
tructure of the viral factories and the dynamics of its
ormation, presently under way, might provide important
ata about the cellular elements that participate in their
iogenesis, the mechanism of incorporation of the core
roteins, and an still unsolved aspect, the encapsidation
f the viral DNA. AMATERIALS AND METHODS
ells and viruses
African green monkey kidney cells (BSC40) and HeLa
ells were grown in DMEM supplemented with 10% new-
orn calf serum. V V strain WR was propagated and
itrated in BSC40 cells. The V V mutant vA5Li that induc-
bly expresses the 39-kDa protein was kindly provided by
r. Merchlinsky and was grown and titrated as previ-
usly described (Williams et al., 1999). Recombinant vi-
us V VindA17L (Rodrı´guez et al., 1995) was grown in
SC40 cells in the presence of 2 mM IPTG. IMVs were
urified according to standard procedures previously
escribed (Joklik, 1962).
ntisera
The rabbit polyclonal anti-39-kDa and anti-p4a/4a an-
isera have been previously described (Demkowicz et al.,
992; Maa and Esteban, 1987). The anti-39-kDa anti-
erum was obtained through immunization with the
hole protein. The rabbit polyclonal anti-p4a/4a serum
as raised through immunization with the 4a protein
also referred to as the 62-kDa protein). A murine poly-
lonal anti-p4a serum (anti-p4a.9K) was generated by
mmunizing mice with a 9-kDa fragment encompassing
mino acids 615–697 from p4a, which was expressed in
scherichia coli as histidine-tagged fusion protein. The
5-kDa V V membrane protein was localized with a rabbit
ntiserum obtained against two synthetic peptides span-
ing amino acids 35–44 and 80–90 (Rodrı´guez et al.,
997). The rabbit polyclonal serum against L1R envelope
rotein was kindly provided by Dr. Hruby (Oregon State
niversity).
etabolic labeling and immunoprecipitation analysis
For continuous labeling, BSC40 cells infected with V V
10 PFU/cell) in the absence or presence of rifampin (100
g/ml) or with the mutant vA5Li in the absence or pres-
nce of 50 mM IPTG were incubated with [35S]methionine
10 mCi/ml) (Amersham) from 6 to 24 h p.i. At the end of
he labeling period, the cells were collected, washed
ith PBS, and resuspended in lysis buffer (20 mM Tris,
H 8.0, containing 80 mM NaCl, 20 mM EDTA, 1% NP-40,
.5% DOC, and 50 mM DTT) in the presence of protease
nhibitors (2 mg/ml bacitracin, 2 mg/ml trypsin inhibitor, 1
M PMSF, and 10 mg/ml leupeptin). When indicated,
.2% SDS was also included in the lysis buffer. After 30
in at 37°C, cell extracts were sonicated and cleared by
entrifugation at 1500 rpm for 5 min. Before immunopre-
ipitation with specific antibodies, cell extracts were
ncubated with preimmune serum coupled to protein
–Sepharose beads (Pharmacia) for 2 h at room temper-
ture. After centrifugation, supernatants were immuno-
recipitated by incubation overnight at 4°C with protein
–Sepharose beads coated with specific antibodies
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384 RISCO ET AL.gainst 39-kDa, L1R, or p4a/4a proteins. The immuno-
recipitates were washed three times with lysis buffer
nd three times with PBS and resuspended in 23 sam-
le buffer (125 mM Tris, pH 6.8, containing 4% SDS, 0.25%
romophenol blue, and 10% 2-mercaptoethanol). Sam-
les were boiled for 3 min and resolved by 10% SDS–
AGE. The gels were dried, and the proteins were visu-
lized after autoradiography.
For pulse-chase analysis, cells were infected with WR
V. At 6 h p.i., cells were washed with methionine-free
MEM and incubated in the same medium for 30 min at
7°C. Cells were then pulse-labeled with [35S]methionine
150 mCi/ml) for 10 min and chased with a 100 fold-
xcess of unlabeled methionine for different times. At the
nd of the chase periods cells, were placed on ice,
ashed 3 times with ice-cold PBS, collected, and resus-
ended in lysis buffer. For total protein profile analysis,
n aliquot of each sample was mixed with an equal
olume of 23 sample buffer. Immunoprecipitation of cell
ysates was performed as described above. Immunopre-
ipitates were resuspended in 23 sample buffer. Total
ell extracts and immunoprecipitated proteins were frac-
ionated by SDS–PAGE and visualized after autoradiog-
aphy of the dried gel.
lectron microscopy
Processing of cell cultures. Cultures of HeLa cells
ere infected at a multiplicity of infection of 5 PFU/cell
ith strain WR in the presence or absence of rifampin
100 mg/ml) or with recombinant virus V VindA17L in the
bsence of IPTG. At 6 h p.i., IPTG (2 mM) was added to
he cultures for 2, 4, or 18 h. At the times indicated, the
upernatant was removed from the cultures, and the cell
onolayers were submitted to a mild fixation with a
olution of 4% paraformaldehyde containing 0.1% glutar-
ldehyde in PBS. Fixed cells were then removed from the
ishes and processed for low-temperature embedding in
owicryl K4M, as previously described in detail (Risco et
l., 1995b). Equivalent cell cultures were submitted to a
tronger fixation with a solution of 2% glutaraldehyde
ontaining 2% tannic acid in PBS and processed for
mbedding in the epoxy-resin EML-812 as previously
escribed (Rodrı´guez et al., 1995). Ultrathin sections
20–30 nm) of the samples were collected in gold grids
overed with Formvar and carbon and were either
tained or processed for immunogold labeling, accord-
ng to general principles previously established (Risco et
l., 1995a; Rodrı´guez et al., 1996).
Immunogold labeling of ultrathin sections. Immuno-
old localization on sections of infected cells was per-
ormed by placing the sections on drops of different
olutions. After a 30-min incubation with Tris buffer gel-
tin (TBG) (30 mM Tris–HCl, pH 8.0, containing 150 mM
aCl, 0.1% BSA, and 1% gelatin) to block nonspecific
inding of the antibodies to the samples, sections wereloated for 90 min on a drop of the specific primary
ntiserum, diluted in TBG (1:100 for all the antisera de-
cribed above). After jet-washing with PBS, grids were
loated on 4 drops of TBG and incubated 10 min on the
ast drop before a 45-min incubation with the secondary
ntibody, a goat anti-rabbit immunoglobulin G conju-
ated with colloidal gold of 10 nm that was purchased
rom BioCell (Cardiff, UK). Washing was repeated as
efore, and grids were then floated on several drops of
istilled water before staining with a solution of satu-
ated uranyl acetate for 20 min (for Lowicryl sections) or
5 min with saturated uranyl acetate followed by 1 min
ith lead citrate for EML 812 sections.
Double labeling experiments were performed accord-
ng to the principles previously described (Risco et al.,
995b). For the simultaneous detection of p4a/4a and 39
Da proteins, we used specific primary antibodies raised
n two different hosts (the mouse anti-P4a-9K and the
abbit anti-39-kDa antisera described above) and the
orresponding secondary antibodies conjugated with
old particles of two different sizes (a 10-nm goat anti-
ouse gold conjugate and a 5-nm goat anti-rabbit gold
omplex). Saturation, incubation times with different re-
gents, and washing steps were performed as described
or single labeling experiments. The double labeling pro-
edure was done in two or four steps, labeling first one
f the proteins with the corresponding primary antibody
nd gold conjugate (four steps) or mixing the primary
ntibodies and later both gold conjugates (two steps).
Samples were studied in a JEOL 1200EX II electron
icroscope.
Immunogold labeling of isolated virions for detection
f V V proteins exposed on the surface of IMVs. Purified
MVs were attached to electron microscopy gold grids
overed with Formvar and carbon that were previously
ade hydrophilic by glow discharge. These grids were
laced on drops of a concentrated IMV suspension, and
irions were adsorbed for 5 min. Adsorbed virions were
ubmitted to immunogold labeling as previously de-
cribed (Risco et al., 1996; Rodrı´guez et al., 1997) and
egatively stained with a 2% solution of uranyl acetate.
amples were finally studied by electron microscopy.
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